Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion type Assertion NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_head.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion wasGeneratedBy ECO_0000203 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion wasDerivedFrom befree-2016 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion SIO_000772 22576344 NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion evidence source_evidence_literature NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.
- NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981182.RApr9ntl-0eB0Xo2859a4S1V3eUw2Y8QsLyg25HsaJA6s130_provenance.